ArticleMolecular cancer therapeutics2024

SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis.

Alexander Ferrena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.